ADVOCATE. CONNECT. INNOVATE.

Board Of Directors

lynch

Casey Lynch

CEO, Co-founder, and Chairman, Cortexyme

Casey Lynch is the CEO, Co-founder and Chairman of Cortexyme, a clinical stage biopharmaceutical company pioneering a novel approach for treatment of Alzheimer’s and other degenerative disorders.  Prior to co-founding Cortexyme, Ms. Lynch co-founded and led various companies and organizations in the biotechnology industry including Aspira Biosystems, Inc. and NeuroInsights, LLC. She served as Aspira’s co-founder, President and Chief Executive Officer from 1999 to 2004 and she co-founded NeuroInsights, LLC and served as its Managing Director from 2004 to 2015. Ms. Lynch also co-founded the Neurotechnology Industry Organization and served as a board member from March 2005 to September 2018. Ms. Lynch oversaw toxicology screening and evaluated new product opportunities at Centaur Pharmaceuticals, including multiple sclerosis, arthritis, and uveitis. Ms. Lynch conducted preclinical testing for Alzheimer’s disease treatment at the Wadsworth Medical Center and researched the neurological basis of schizophrenia and epilepsy at UCLA. Her graduate work on neurotrophic factor cell biology and neurodegenerative diseases, was carried out at UCSF and Stanford University. Ms. Lynch holds a B.S. in Neuroscience from the University of California, Los Angeles, an M.S. in Neuroscience from the University of California, San Francisco and completed the Management Development for Entrepreneurs Program at University of California, Los Angeles.